Teva Pharmaceutical Industries Ltd. (TEVA)
31.76
-0.59
(-1.82%)
USD |
NYSE |
Jan 16, 16:00
31.80
+0.04
(+0.13%)
After-Hours: 20:00
Teva Pharmaceutical Industries Market Cap: 36.44B for Jan. 16, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 177.92B |
| Novo Nordisk A/S | 276.96B |
| Pfizer Inc. | 145.84B |
| Compugen Ltd. | 220.74M |
| Can-Fite BioPharma Ltd. | 3.414M |
Market Cap Related Metrics
| PE Ratio | 51.79 |
| PS Ratio | 2.172 |
| Price to Book Value | 5.026 |
| Price to Free Cash Flow | 145.94 |
| Price | 31.76 |
| Earnings Yield | 1.93% |
| Operating PE Ratio | 10.18 |
| Normalized PE Ratio | 19.12 |